Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-24 pm EST			5-day change	1st Jan Change
77.05 ^USD	+0.18%		+1.61%	+6.97%

Jan. 14	Bio-Techne Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 10:30 AM
Jan. 10	Bio-Techne Expands R&D Systems Ai-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine	CI

Bio-Techne Corporation, Q1 2025 Earnings Call, Oct 30, 2024

October 30, 2024 at 09:00 am EDT

Presentation Operator Message
Operator (Operator)

Good morning and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2025. [Operator Instructions]

This article is reserved for subscribers

To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Bio-Techne Corporation

Bio-Techne Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 10:30 AM	Jan. 14
Bio-Techne Expands R&D Systems Ai-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine	Jan. 10	CI
Bio-Techne Prevails in Second Reverse Engineering Claim by Miltenyi Biotec; Shares Up	Jan. 07	MT
Bio-Techne, Waters Strike Co-Marketing, Co-Promotion Deal	Dec. 19	MT
Bio-Techne Signs Distribution Deal With MedSanTek to Expand Product Reach in Turkey	Dec. 12	MT
Medsantek Co. Partners with Bio-Techne Corporation to Bring World-Class Products and Diagnostics in Turkey and Azeri Markets	Dec. 12	CI
Bio-Techne Corporation Presents at Citi's 2024 Global Healthcare Conference, Dec-04-2024 03:15 PM	Dec. 04
Bio-Techne's Select Fetal Bovine Serum Product Rights, Inventory Acquired by Gemini Bioproducts	Nov. 25	MT
Gemini Bio-Products, Inc. acquired Assets of Bio-Techne Corporation.	Nov. 24	CI
Bio-Techne Corporation Presents at Stephens 26th Annual Investment Conference \| NASH2024, Nov-20-2024 11:00 AM	Nov. 20
Bio-Techne Signs Distribution Deal With Leader Life Sciences	Nov. 20	MT
Bio-Techne Corporation Announces New Distribution Agreement with Leader Life Sciences	Nov. 20	CI
Bio-Techne Corporation Presents at Stifel 2024 Healthcare Conference, Nov-19-2024 08:00 AM	Nov. 19
Bio-Techne Corporation and ALZpath, Inc Announce Strategic Partnership to Advance Neurodegenerative Disease Research	Nov. 18	CI
Bio-Techne Corporation to Highlight Novel Solutions for Cancer and Carrier Screening At Amp 2024 Annual Meeting & Expo	Nov. 14	CI
Bio-Techne Corporation Presents at UBS Global Healthcare Conference 2024, Nov-12-2024 09:30 AM	Nov. 12
Bio-Techne Corporation to Present at the Society for Immunotherapy of Cancer 39Th Annual Meeting	Nov. 06	CI
Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on February 1, 2022.	Nov. 05	CI
Bio-Techne Corporation Announces the Release of Clinically Relevant Spatial Biology Data	Nov. 05	CI
Scotiabank Adjusts Bio-Techne's Price Target to $88 From $83	24-10-31	MT
Baird Adjusts Bio-Techne's Price Target to $84 From $82	24-10-31	MT
Stifel Adjusts Bio-Techne's Price Target to $75 From $65	24-10-31	MT
RBC Adjusts Bio-Techne's Price Target to $79 From $77	24-10-31	MT
Bio-Techne Corporation, Q1 2025 Earnings Call, Oct 30, 2024	24-10-30
Earnings Flash (TECH) BIO-TECHNE CORPORATION Posts Q1 Revenue $289.5M	24-10-30	MT